Clinical trial
Insomnia and Drug Relapse Risk
NCT00253890 · Butler Hospital, Other · Completed
Key facts
| NCT number | NCT00253890 |
|---|---|
| Title | Insomnia and Drug Relapse Risk |
| Official title | Insomnia and Drug Relapse Risk |
| Lead sponsor | Butler Hospital, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Poor Quality Sleep, Opiate Addiction |
| Intervention type | Drug |
| Interventions | Trazodone, Placebo |
| Enrollment | 137 |
| Start date | Oct 1, 2005 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Nov 15, 2005 |
| Last update posted | Dec 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: